|[June 26, 2014]
SHAREHOLDER ALERT: Brower Piven Announces The Investigation Of Auxilium Pharmaceuticals Inc. In Connection With The Proposed Sale Of The Company To QLT Inc.
STEVENSON, Md. --(Business Wire)--
The securities litigation law firm of Brower Piven, A Professional
Corporation, has commenced an investigation into possible breaches of
fiduciary duty and other violations of state law by the board of
directors of Auxilium Pharmaceuticals Inc. ("Auxilium" or the "Company")
(NASDAQ: AUXL) relating to the proposed buyout of the Company by QLT
On June 26, 2014, Auxilium announced that it had entered into a
definitive agreement under which Auxilium plans to merge with QLT in an
all-stock deal valued at approximately $851 million.
Under the terms of the transaction, Auxilium shareholders will receive
3.1359 QLT shares for each share of Auxilium ommon stock they own. The
firm's investigation seeks to determine, among other things, whether the
Company's board of directors breached their fiduciary duties by failing
to maximize shareholder value before agreeing to enter into this
transaction, and whether QLT is underpaying for Auxilium shares.
If you currently own common stock of Auxilium and would like to learn
more about the investigation being conducted by Brower Piven, without
cost or obligation to you, please visit our website at http://www.browerpiven.com/currentinvestigations.html.
You may also request more information by contacting Brower Piven either
by email at firstname.lastname@example.org
or by telephone at (410) 415-6616.
Attorneys at Brower Piven have extensive experience in litigating
securities and other class action cases and have been advocating for the
rights of shareholders since the 1980s.
[ Back To TMCnet.com's Homepage ]